Header Logo

Connection

Gregory Valania to Treatment Outcome

This is a "connection" page, showing publications Gregory Valania has written about Treatment Outcome.
Connection Strength

0.043
  1. Ezenna C, Krishna MM, Joseph M, Pereira V, Nadeem S, Valania G, Goldsweig AM. The Efficacy and Safety of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. Am J Cardiol. 2025 Apr 15; 241:52-60.
    View in: PubMed
    Score: 0.029
  2. Lee MS, Rametta S, Aragon J, Khan A, Wilentz J, Singh V, Levitt H, Kamra A, Valania G, Makkar R. New heparin dosing regimen for diabetics undergoing percutaneous coronary intervention. J Invasive Cardiol. 2005 May; 17(5):248-50.
    View in: PubMed
    Score: 0.007
  3. Lee MS, Makkar R, Singh V, Rametta S, Valania G, Platzman Z, Wilentz J. Pre-procedural administration of aminophylline does not prevent AngioJet rheolytic thrombectomy-induced bradyarrhythmias. J Invasive Cardiol. 2005 Jan; 17(1):19-22.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.